Eu Yan Sang to be acquired by Japan's Rohto Pharma, Mitsui for $800m
One of Singapore's oldest homegrown brands Eu Yan Sang will be acquired by Japan's Rohto Pharmaceutical and Mitsui & Co. The deal for the 144-year-old Traditional Chinese Medicine firm is valued at $800 million. Eu Yan Sang operates over 170 retail outlets and 30 TCM clinics, mainly in Singapore, Hong Kong and Malaysia. The deal is expected to be completed around Jun 30. Eventually, Rohto is expected to hold about 60% of the shares and Mitsui 3 per cent. The founding family of Eu Yan Sang will keep the remaining 10 per cent.
One of Singapore's oldest homegrown brands Eu Yan Sang will be acquired by Japan's Rohto Pharmaceutical and Mitsui & Co. The deal for the 144-year-old Traditional Chinese Medicine firm is valued at $800 million. Eu Yan Sang operates over 170 retail outlets and 30 TCM clinics, mainly in Singapore, Hong Kong and Malaysia. The deal is expected to be completed around Jun 30. Eventually, Rohto is expected to hold about 60% of the shares and Mitsui 3 per cent. The founding family of Eu Yan Sang will keep the remaining 10 per cent.
Popular Shows
